Edition:
United States

People: Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

3.39USD
14 Jun 2019
Change (% chg)

$-0.04 (-1.17%)
Prev Close
$3.43
Open
$3.43
Day's High
$3.47
Day's Low
$3.36
Volume
8,469
Avg. Vol
33,998
52-wk High
$4.30
52-wk Low
$2.00

Bizzari, Jean-Pierre 

Dr. Jean-Pierre Bizzari has been appointed Director at Compugen Ltd. effective September 5, 2018. He is a world-renowned oncology expert, member of the Scientific Advisory Board of the French National Cancer Institute and European Organization of Research and Treatment of Cancer and Chairman of the New Drug Advisory Committee. He holds Directorship at a variety of biotech companies. Dr. Bizzari holds a Doctorate of Medicine degree, specializing in oncology, from the University of Nice (France) completed with training at the Pitie-Salpetriere hospital in Paris, the Ontario Cancer Institute and at The McGill Rosalind and Morris Goodman Cancer Research Centre (formerly the McGill Cancer Center) in Montreal, Canada.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --